The University of Chicago Header Logo

Connection

Peter Nagele to Antidepressive Agents

This is a "connection" page, showing publications Peter Nagele has written about Antidepressive Agents.
Connection Strength

0.777
  1. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial. Biol Psychiatry. 2015 Jul 01; 78(1):10-18.
    View in: PubMed
    Score: 0.465
  2. A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Sci Transl Med. 2021 06 09; 13(597).
    View in: PubMed
    Score: 0.182
  3. Nitrous Oxide, a Rapid Antidepressant, Has Ketamine-like Effects on Excitatory Transmission in the Adult Hippocampus. Biol Psychiatry. 2022 12 15; 92(12):964-972.
    View in: PubMed
    Score: 0.049
  4. Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents. J Neurol Sci. 2020 05 15; 412:116778.
    View in: PubMed
    Score: 0.042
  5. European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice. Br J Anaesth. 2019 May; 122(5):587-604.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.